BAYER ADVANCED GARDEN 2-in-1 Systemic Rose & Flower Care

SECTION 2: Hazards identification

EMERGENCY OVERVIEW * WARNING! Color Dark gray; Form Solid; Granules; Odor * Bitter bubble gum; Organophosphate Insecticide - * * Cholinesterase Inhibitor; May be fatal if swallowed. * *****************************************************************

Principle Routes of Exposure

Inhalation; Skin Contact; Skin Absorption; Eye Contact; Ingestion HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE: ACUTE EFFECTS OF EXPOSURE.....: Exposure during the labeled use of this product is expected to be minimal. Consumers should refer to the packaging label for proper handling procedures. However, sufficient exposure to disulfoton, the active ingredient in this product, may result in systemic intoxication due to inhibition of the enzyme cholinesterase. The sequence of development of systemic effects varies with the route of entry, and the onset of symptoms may be delayed up to 12 hours. First symptoms of poisoning may be nausea, increased salivation, lacrimation, blurred vision and constricted pupils. Other symptoms of systemic poisoning include vomiting, diarrhea, abdominal cramping, dizziness and sweating. After inhalation, respiratory symptoms like tightness of chest, wheezing, and laryngeal spasms, may be pronounced at first. If the poisoning is severe, then symptoms of convulsions, low blood pressure, cardiac irregularities, loss of reflexes and coma may occur. In extreme cases, death may occur due to a combination of factors such as respiratory arrest, paralysis of respiratory muscles or intense bronchoconstrictions. Complete symptomatic recovery from sublethal poisoning usually occurs within one week once the source of exposure is completely removed. The fertilizer contained in this product may cause eye, skin or mucous membrane irritation. Ingestion may cause nausea.

Potential chronic health

OF EXPOSURE... Cholinesterase inhibition sometimes persists for 2-6 weeks, thus repeated exposure to small amounts of this material may result in an unexpected cholinesterase depression causing symptoms such as malaise, weakness, and anorexia that resemble other illnesses such as influenza. Exposure to a concentration that would not have produced symptoms in a person that was not previously exposed may produce severe symptoms of cholinesterase inhibition in a previously exposed person. CARCINOGENICITY...............: This product is not listed by NTP, IARC or regulated as a carcinogen by